Malaya United Corp.

CarciScan

CarciScan

CarciScan HPV Kit for Cervical Cancer Screening (genoma)

This product aims to enhance early cervical cancer detection for women. Many avoid screenings due to cost, distance, or accessibility. The solution offers simple self-sampling, allowing women to privately and safely take the first step without an immediate hospital visit. Samples are tested using PCR-based HPV DNA detection for reliable results.

High-performance Test (PCR)

PCR-based HPV DNA detection (“highly sensitive PCR-based detection”)

>95% accuracy 

Scientifically validated

"Independently verified by the Karolinska Institute (Sweden)"

Focus on High-Risk Types

-HPV 16/18/45
-IFU CarciScan: detects multiple high-risk HPV types including HPV16, HPV18, HPV31, HPV33, HPV45, and HPV52.

Self-sampling possible (game changer)

Home use is explicitly intended (self-sampling kits can also be used clinically)

Extreme Scalability

Production capacity: up to 1,000,000 kits per month

Price/Scaling Argument

"Price barrier is drastically reduced."

Fast Resuts

Results 24–48 hours after sample arrives at the lab

Real-World Use

Already in use in Ghana and Turkey